Search by Drug Name or NDC

    NDC 41250-0239-79 Allergy Relief-D 10; 240 mg/1; mg/1 Details

    Allergy Relief-D 10; 240 mg/1; mg/1

    Allergy Relief-D is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by MEIJER, INC.. The primary component is LORATADINE; PSEUDOEPHEDRINE SULFATE.

    Product Information

    NDC 41250-0239
    Product ID 41250-239_f4b96094-f1ed-4597-ba7a-17e7031d64d3
    Associated GPIs 43993002597520
    GCN Sequence Number 027622
    GCN Sequence Number Description loratadine/pseudoephedrine TAB ER 24H 10MG-240MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 63577
    HICL Sequence Number 006605
    HICL Sequence Number Description LORATADINE/PSEUDOEPHEDRINE SULFATE
    Brand/Generic Generic
    Proprietary Name Allergy Relief-D
    Proprietary Name Suffix 24 Hour
    Non-Proprietary Name Loratadine and Pseudoephedrine Sulfate
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 10; 240
    Active Ingredient Units mg/1; mg/1
    Substance Name LORATADINE; PSEUDOEPHEDRINE SULFATE
    Labeler Name MEIJER, INC.
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075706
    Listing Certified Through n/a

    Package

    NDC 41250-0239-79 (41250023979)

    NDC Package Code 41250-239-79
    Billing NDC 41250023979
    Package 2 BLISTER PACK in 1 CARTON (41250-239-79) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2016-03-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 3e3045a0-5ba7-4747-bd01-a747510b72ee Details

    Revised: 10/2021